A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.

NCT00381394 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Leishmaniasis, Visceral

Interventions

DRUG: sitamaquine

Sponsor

GlaxoSmithKline